4//SEC Filing
PYSZCZYMUKA GREG 4
Accession 0001437749-25-030650
CIK 0001385818other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:16 PM ET
Size
15.7 KB
Accession
0001437749-25-030650
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-10-03+12,500→ 36,102 total
Footnotes (1)
- [F1]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001952920
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:16 PM ET
- Size
- 15.7 KB